Systemic in vivo antitumor activity of interleukin-12 against both transplantable and primary tumor

被引:14
|
作者
Nishimura, T
Watanabe, K
Lee, U
Yahata, T
Ando, K
Kimura, M
Hiroyama, Y
Kobayashi, M
Herrmann, SH
Habu, S
机构
[1] TOKAI UNIV,SCH MED,DEPT INFECT DIS,ISEHARA,KANAGAWA 25911,JAPAN
[2] TOKAI UNIV,SCH MED,DEPT MOLEC LIFE SCI,ISEHARA,KANAGAWA 25911,JAPAN
[3] DNARD INC,KAWASAKI,KANAGAWA 216,JAPAN
[4] GENET INST INC,CAMBRIDGE,MA 02140
关键词
interleukin-12; tumor immunotherapy; primary tumor; mouse;
D O I
10.1016/0165-2478(95)02448-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:149 / 152
页数:4
相关论文
共 50 条
  • [41] Overexpression of interleukin-12 enables dendritic cells to activate NK cells and confer systemic antitumor immunity
    Miller, G
    Lahrs, S
    DeMatteo, RP
    FASEB JOURNAL, 2003, 17 (02): : 728 - +
  • [42] Interleukin-12 induces an effective antitumor response in malignant mesothelioma
    Caminschi, I
    Venetsanakos, E
    Leong, CC
    Garlepp, MJ
    Scott, B
    Robinson, BWS
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1998, 19 (05) : 738 - 746
  • [43] Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model
    Kazuki Yamanaka
    Isao Hara
    Hiroshi Nagai
    Hideaki Miyake
    Kazuo Gohji
    Mark J. Micallef
    Masashi Kurimoto
    Soichi Arakawa
    Sadao Kamidono
    Cancer Immunology, Immunotherapy, 1999, 48 : 297 - 302
  • [44] Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model
    Yamanaka, K
    Hara, I
    Nagai, H
    Miyake, H
    Gohji, K
    Micallef, MJ
    Kurimoto, M
    Arakawa, S
    Kamidono, S
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1999, 48 (06) : 297 - 302
  • [45] Transfection of interleukin-12 cDNAs into tumor cells enhances cytotoxic responses against native tumor.
    Hoshino, T
    Jiang, YZ
    Dunn, D
    Wang, J
    Barrett, AJ
    Liu, JM
    BLOOD, 1996, 88 (10) : 534 - 534
  • [46] INTERLEUKIN-12 ENHANCES PERIPHERAL HEMATOPOIESIS IN-VIVO
    JACKSON, JD
    YAN, Y
    BRUNDA, MJ
    KELSEY, LS
    TALMADGE, JE
    BLOOD, 1995, 85 (09) : 2371 - 2376
  • [47] Interleukin-12 Producing Genetically Engineered Macrophages to Reinvigorate Antitumor Immunity Against Advanced Gastrointestinal Cancer
    Labadie, Kevin P.
    Kreuser, Shannon A.
    Brempelis, Katherine J.
    Sullivan, Kevin M.
    Daniel, Sara K.
    Kenerson, Heidi K.
    Yeung, Raymond S.
    Kim, Teresa S.
    Crane, Courtney A.
    Pillarisetty, Venu G.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (04) : S267 - S268
  • [48] T-cell Delivery of Interleukin-12 to the Tumor Microenvironment Triggers Potent Endogenous Antitumor Responses
    Kerkai, Sid P.
    Muranski, Pawel
    Boni, Andrea
    Kaiser, Andrew
    Sanchez-Perez, Luis
    Cassard, Lydie
    Gattinoni, Luca
    Palmer, Douglas
    Yu, Zhiya
    Ji, Yun
    Sukumar, Madhu
    Reger, Robert
    Garvin, Lindsay
    Zhang, Ling
    Morgan, Richard A.
    Trinchieri, Giorgio
    Rosenberg, Steven A.
    Restifo, Nicholas P.
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (09) : 946 - 946
  • [49] In vivo activity of plant-based interleukin-12 in the lung of Balb/c mouse
    Snchez-Hernndez C.
    Gutiérrez-Ortega A.
    Aguilar-Leán D.
    Hernndez-Pando R.
    Gámez-Lim M.
    Gámez-García B.
    BMC Research Notes, 3 (1)
  • [50] Modulation of Interleukin-12 activity in the presence of heparin
    Jayanthi, Srinivas
    Koppolu, Bhanu Prasanth
    Nguyen, Khue G.
    Smith, Sean G.
    Felber, Barbara K.
    Kumar, Thallapuranam Krishnaswamy Suresh
    Zaharoff, David A.
    SCIENTIFIC REPORTS, 2017, 7